A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) receptor agonists, particularly semaglutide and liraglutide, may be effective treatments for alcohol use disorder
Lipid Panel Weight change is the hidden driver behind many cholesterol moves, not the semaglutide molecule itself
The active compounds themselves have been studied extensively
Before and after pictures can help you track your progress and see the changes in your body
At 6 Months Many patients reach: 1015% total body weight loss At 12 Months Some patients achieve: 1520%+ total body weight loss These results can significantly improve: Blood sugar Blood pressure Cholesterol Joint pain Overall metabolic health Ozempic vs Wegovy: Whats the Difference
Participants received weekly injections of survodutide at doses of 3.6 milligrams or 6.0 milligrams, or a placebo, over nearly a year and a half